Clinical Trial Update: BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) [Phase 4]

View source ↗

Summary

Phase 4 trial update for BAY14-2222 in adults evaluating prophylaxis and joint function in hemophilia A; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BAY14-2222

Snippet

Sponsor: Bayer | Conditions: Hematologic Disease, Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2009-11-19